Harms of Restrictive Risk-Based Mammographic Breast Cancer Screening

AJR. American Journal of Roentgenology
Colleen H NealM A Helvie

Abstract

The objective of this study was to determine if restrictive risk-based mammographic screening could miss breast cancers that population-based screening could detect. Through a retrospective search of records at a single institution, we identified 552 screen-detected breast cancers in 533 patients. All in situ and invasive breast cancers detected at screening between January 1, 2011, and December 31, 2014, were included. Medical records were reviewed for history, pathology, cancer size, nodal status, breast density, and mammographic findings. Mammograms were interpreted by one of 14 breast imaging radiologists with 3-30 years of experience, all of whom were certified according to the Mammography Quality Standards Act. Patient ages ranged from 36 to 88 years (mean, 61 years). The breast cancer risks evaluated were family history of breast cancer and dense breast tissue. Positive family history was defined as a first-degree relative with breast cancer. Dense breast parenchyma was either heterogeneously or extremely dense. Group 1 consisted of the 76.7% (409/533) of patients who had no personal history of breast cancer. Of these patients, 75.6% (309/409) had no family history of breast cancer, and 56% (229/409) had nondense breasts...Continue Reading

References

Mar 1, 1985·International Journal of Epidemiology·G Rose
May 1, 1995·AJR. American Journal of Roentgenology·B N CurpenS D Frankel
Jan 1, 1997·Journal of the National Cancer Institute. Monographs·R E HendrickC R Smart
Sep 17, 1998·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·M Gail, B Rimer
Dec 5, 2000·Annals of Internal Medicine·K KerlikowskeR Ballard-Barbash
Apr 5, 2003·Annals of Surgery·S Eva Singletary
May 3, 2003·Lancet·Suzie J OttoUNKNOWN National Evaluation Team for Breast Cancer Screening
Sep 23, 2006·Radiology·Robert D RosenbergRachel Ballard-Barbash
Apr 4, 2007·Annals of Internal Medicine·Amir QaseemUNKNOWN Clinical Efficacy Assessment Subcommittee of the American College of Physicians
Nov 19, 2009·Annals of Internal Medicine·Heidi D NelsonUNKNOWN U.S. Preventive Services Task Force
Jul 21, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Karla KerlikowskeDiana L Miglioretti
Feb 22, 2012·Breast Cancer Research and Treatment·Graham A ColditzBernard Rosner
May 2, 2012·Annals of Internal Medicine·Heidi D NelsonDiana L Miglioretti
Apr 5, 2013·JAMA Internal Medicine·Karla KerlikowskeUNKNOWN Breast Cancer Surveillance Consortium
Feb 6, 2014·PloS One·Ester VilaprinyoUNKNOWN Interval Cancer (INCA) Study Group
Jul 24, 2015·AJR. American Journal of Roentgenology·Elissa R PriceBonnie N Joe
Oct 8, 2015·BMJ : British Medical Journal·Sepideh SaadatmandMadeleine M A Tilanus-Linthorst
Oct 27, 2015·JAMA : the Journal of the American Medical Association·Kevin C OeffingerUNKNOWN American Cancer Society
Aug 23, 2016·Annals of Internal Medicine·Amy Trentham-DietzUNKNOWN Breast Cancer Surveillance Consortium and the Cancer Intervention and Surveillance Modeling Network

❮ Previous
Next ❯

Citations

Dec 18, 2018·AJR. American Journal of Roentgenology·Cindy S LeeLinda Moy
Jun 12, 2019·Radiology·Bonnie N Joe, Jessica H Hayward
Nov 13, 2019·AJR. American Journal of Roentgenology·Cindy S LeeLinda Moy
Jun 2, 2020·Radiographics : a Review Publication of the Radiological Society of North America, Inc·Reni Butler
Dec 10, 2020·The American Surgeon·Maria CastaldiRifat Latifi
Jun 26, 2021·Preventive Medicine Reports·Dinesh Pal MudaranthakamTami Gurley-Calvez

❮ Previous
Next ❯

Related Concepts

Related Feeds

Carcinoma, Ductal

Ductal carcinoma is a malignant neoplasm involving the ductal systems of any of a number of organs, such as the mammary glands, pancreas, prostate or lacrimal gland. Discover the latest research on ductal carcinoma here.